Companies · USAspending parent record
EMERGENT BIOSOLUTIONS INC
Stock ticker: EBS. 1 recipient record grouped under this USAspending parent (UEI DKEFA8JAW3X4).
obligated to date on 2 non-competed awards of $1M+ signed FY2024–26
Obligated to date, not spending in a year. Selected awards only (rule r5-v1): not this company's not-competed share.
obligated to date: W911SR24F0016, Department of Defense, signed FY2024
reported in EBS by 2 members of Congress
Filings: House 2021–2026 · Senate 2024–2026
Federal contract awards in our records
Each row is one prime contract award on USAspending.gov; “USAspending” opens its official page.
What this table covers: every award signed in FY2024–26 that the agency coded “not competed” and that is $1 million or more, plus any award of $10 million or more (rule r5-v1). Smaller competed awards are not in it, so it is not this company’s total federal business and it cannot show a not-competed share. “Obligated to date” is the total committed on the award so far, including later modifications (USAspending, as of Oct 3, 2026), not the amount at any earlier date.
| Signed in | Non-competed awards | Obligated to date | Other awards $10M+ | Obligated to date |
|---|---|---|---|---|
| FY2024 | 1 | $41.8M | None in this set | — |
| FY2025 | None in this set | — | None in this set | — |
| FY2026incomplete | 1 | $21.5M | None in this set | — |
FY2026 is incomplete: the Department of Defense reports contract actions 90 days late, and older awards keep growing through modifications, so these amounts will rise. Source: USAspending.gov, as of Oct 3, 2026.
No rows to show.
Recipient records grouped under this company (1)
USAspending groups recipients by its parent-company field, which has known errors. Check that the recipients below belong to EMERGENT BIOSOLUTIONS INC; the stock link below is made per recipient.
- EMERGENT BIODEFENSE OPERATIONS LANSING LLC2 awards · 2 non-competed, $63.3M obligated to date
Stock ticker
Links between a federal contract recipient and an SEC-registered company, made by a written rule from SEC filings and USAspending records. Only confirmed links are shown.
How these recipients were linked (1)
- EMERGENT BIODEFENSE OPERATIONS LANSING LLCsubsidiary of the registrant (name match or SEC subsidiary list) · USAspending parent 'EMERGENT BIOSOLUTIONS INC' = registrant; recipient name starts with 'EMERGENT', a distinctive word of the parent name · rule r7-v1
A link says USAspending and SEC records tie this recipient to this registrant. It does not say a member’s trade or a company’s award means anything.
Members of Congress who reported trading this stock
Trades in EBS from STOCK Act disclosures, newest filing first.
Two public records, side by side. The company holds federal contracts, and members reported trades in its stock. That is a pattern in the records, not an accusation: trades can be routine, made by a spouse or a managed account, and a sequence of events is not proof of wrongdoing. Amounts are the ranges members disclosed; they are never added up into a single figure, and “2 ×” means two same-day lots, each in that range.
2 members · 5 reported trades
| Josh Gottheimer | D · NJ · House | 4 | 1 | 3 | 0 | 0 | Dec 13, 2021 |
|---|---|---|---|---|---|---|---|
| Steve Cohen | D · TN · House | 1 | 0 | 1 | 0 | 0 | Jan 10, 2025 |
Members who reported trades in this stock, by number of reported trades
- D · NJ · House
- Reported trades
- 4
- Purchases
- 1
- Sales
- 3
- Exchanges
- 0
- Options and other
- 0
- Latest filing
- Dec 13, 2021
- D · TN · House
- Reported trades
- 1
- Purchases
- 0
- Sales
- 1
- Exchanges
- 0
- Options and other
- 0
- Latest filing
- Jan 10, 2025
Every reported trade, with its filing
| Filing | |||||
|---|---|---|---|---|---|
| Steve CohenD · TN · House · owner: Self (incl. trusts/accounts) | EBS Emergent BioSolutions Inc. Common Stock | Sale | $1,001–$15,000 | Dec 11, 2024 → Jan 10, 2025 | View filing |
| Josh GottheimerD · NJ · House · owner: Joint | EBS Emergent biosolutions, Inc. | Sale | $1,001–$15,000 | Nov 5, 2021 → Dec 13, 2021 | View filing |
| Josh GottheimerD · NJ · House · owner: Joint | EBS Emergent biosolutions, Inc. | Purchase | $1,001–$15,000 | Oct 18, 2021 → Nov 15, 2021 | View filing |
| Josh GottheimerD · NJ · House · owner: Joint | EBS Emergent biosolutions, Inc. | Sale | $1,001–$15,000 | Sep 15, 2021 → Oct 13, 2021 | View filing |
| Josh GottheimerD · NJ · House · owner: Joint | EBS Emergent biosolutions, Inc. | Sale | $1,001–$15,000 | Feb 23, 2021 → Mar 10, 2021 | View filing |
Reported trades in EBS, newest filing first
- Steve CohenD · TN · House · owner: Self (incl. trusts/accounts)EBS Emergent BioSolutions Inc. Common Stock
- Type
- Sale
- Amount (range)
- $1,001–$15,000
- Traded → filed
- Dec 11, 2024 → Jan 10, 2025
- Josh GottheimerD · NJ · House · owner: JointEBS Emergent biosolutions, Inc.
- Type
- Sale
- Amount (range)
- $1,001–$15,000
- Traded → filed
- Nov 5, 2021 → Dec 13, 2021
- Josh GottheimerD · NJ · House · owner: JointEBS Emergent biosolutions, Inc.
- Type
- Purchase
- Amount (range)
- $1,001–$15,000
- Traded → filed
- Oct 18, 2021 → Nov 15, 2021
- Josh GottheimerD · NJ · House · owner: JointEBS Emergent biosolutions, Inc.
- Type
- Sale
- Amount (range)
- $1,001–$15,000
- Traded → filed
- Sep 15, 2021 → Oct 13, 2021
- Josh GottheimerD · NJ · House · owner: JointEBS Emergent biosolutions, Inc.
- Type
- Sale
- Amount (range)
- $1,001–$15,000
- Traded → filed
- Feb 23, 2021 → Mar 10, 2021
Looking for agency-level shares? See non-competed share by agency.